R.k. DeLong

Dec 2, 2024 | cellandgene.com | Antony Hitchcock |AGH Bioconsulting |R.k. DeLong

Webinar: Leveraging Platform Processes for Developing and Accelerating Novel Gene and Cancer TherapeuticsThe FDA's new draft guidance for the Platform Technology Designation Program helps drug developers leverage platform data to speed approvals and improve patient access. In an upcoming webinar, experts will discuss platform processes, supply chain integration, and share insights on combining AAV gene therapy with cytokine immunotherapy to treat cancer. Click here to learn more.